John has over 25 years of financial and operational experience in the pharmaceutical and medical device arenas. Prior to joining Alyve Medical, John was CFO of Bolder Surgical and led the M&A team during the successful sale of Bolder Surgical to Hologic, Inc. in December 2021. John also co-founded Micro-Imaging Solutions whereby he led the finance and business development efforts for over 15 years. Prior to that role, John spent most of his career as a finance executive with large, multi-national corporations including Akzo-Nobel NV, Amgen and Thermo Fisher Scientific. John is a graduate of both Colorado State University where he earned a BS in Accounting and the University of Colorado-Denver where he earned an MS in Finance. John is also a CPA.
Org chart
Teams
Offices
This person is not in any offices
Rhaeos
1 followers
Rhaeos is a VC backed, clinical stage medical device company developing FlowSense, a platform technology and a noninvasive wireless, wearable skin patch that can assess and monitor fluid flow subdermally throughout the body. The company is initially targeting hydrocephalus, a life threatening condition caused by an abnormal accumulation of cerebrospinal fluid (CSF). Implantable shunts, the gold standard treatment, often fail, leading to multiple trips to the emergency room and repeat surgeries. There is no technology available today that can easily assess CSF flow in shunts wirelessly, bedside, and without capital equipment until now.
